SO
AEGR

STRS Ohio’s Aegerion Pharmaceuticals AEGR Stock Holding History

STRS Ohio’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-44,000
Closed -$598K – 2004
2015
Q3 		$598K Buy
+44,000
New +$783K ﹤0.01% 1183
2014
Q3 		– Sell
-24,100
Closed -$748K – 1870
2014
Q2 		$773K Buy
24,100
+1,600
+7% +$59.6K ﹤0.01% 954
2014
Q1 		$1.04M Buy
22,500
+2,000
+10% +$117K ﹤0.01% 714
2013
Q4 		$1.46M Sell
20,500
-800
-4% -$61.2K 0.01% 597
2013
Q3 		$1.83M Buy
21,300
+800
+4% +$67.8K 0.01% 579
2013
Q2 		$1.3M Buy
+20,500
New +$1.09M 0.01% 701

Other funds holding AEGR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

STRS Ohio's AEGR Position: Q4 2015 in Review

STRS Ohio sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2015, closing a stake of 44,000 shares — an estimated $598K sold.

STRS Ohio first reported a position in AEGR in Q2 2013 and held it in 6 quarters. The position peaked at $1.83M in Q3 2013. 109 funds tracked by Wall St. Rank hold AEGR as of Q4 2015.

  • STRS Ohio reported no remaining Aegerion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • STRS Ohio sold 44,000 Aegerion Pharmaceuticals shares in Q4 2015, an estimated $598K.
  • STRS Ohio first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • STRS Ohio's Aegerion Pharmaceuticals position peaked at $1.83M in Q3 2013.
  • 109 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2015.

Based on STRS Ohio's 13F filing for Q4 2015, filed 28 Jan 2016.